Del C. Valle-Fernandez
Cadiz, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: Validation of the Spanish version of the EORTC QLQ-CML24 questionnaire for assessment of health-related quality of life in patients with chronic myeloid leukemia.
Journal: Annals of hematology
Published: September 05, 2025
Computational pathology identifies a low B-cell content in the tumour microenvironment as a predictor of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD.
Journal: Journal of clinical pathology
Published: September 06, 2024
Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
Journal: International journal of molecular sciences
Published: December 25, 2023
New Cases and Mutations in SEC23B Gene Causing Congenital Dyserythropoietic Anemia Type II.
Journal: International journal of molecular sciences
Published: April 20, 2023
Identification of prognostic factors in classic Hodgkin lymphoma by integrating whole slide imaging and next generation sequencing.
Journal: Molecular omics
Published: November 16, 2022
The Need for Standardization in Next-Generation Sequencing Studies for Classic Hodgkin Lymphoma: A Systematic Review.
Journal: Diagnostics (Basel, Switzerland)
Published: March 14, 2022
Hypersensitivity to alemtuzumab. A safe and effective desensitization protocol: A case report.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 25, 2018
Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?
Journal: American journal of hematology
Published: July 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026